Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.316
Filtrar
1.
Viruses ; 16(8)2024 Aug 20.
Artigo em Inglês | MEDLINE | ID: mdl-39205303

RESUMO

This study investigated the potential associations between hepatitis virus antibody status and thyroid and inflammatory function. The C-reactive protein (CRP), thyroid-stimulating hormone (TSH), and free thyroxine (FT4) levels were measured in individuals with and without antibodies to the hepatitis A virus (HAV) and hepatitis B virus (HBV). Participants were stratified by age, sex, and HAV/HBV antibody status. Participants with and without antibodies to HAV and HBV had normal CRP, TSH, and FT4 levels. However, notable discrepancies were observed in FT4 levels among participants with HAV antibodies and in CRP and FT4 levels among those with both HAV and HBV antibodies, suggesting potential associations between viral immunity and thyroid function, especially in younger participants. Significant variations in thyroid hormone levels were noted when the sample was stratified by sex and HAV and HBV antibody status, indicating that the association between antibody status and thyroid hormone levels varied by sex. This study underscores the need for further research on the effect of viral immunity on inflammatory parameters and thyroid hormone levels.


Assuntos
Hepatite A , Hepatite B , Hormônios Tireóideos , Humanos , Feminino , Masculino , Adulto , Pessoa de Meia-Idade , Hepatite A/imunologia , Hepatite A/sangue , Hepatite A/virologia , Hepatite B/imunologia , Hepatite B/virologia , Hepatite B/sangue , Hormônios Tireóideos/sangue , Adulto Jovem , Fatores Sexuais , Vírus da Hepatite A/imunologia , Proteína C-Reativa/análise , Vírus da Hepatite B/imunologia , Anticorpos Anti-Hepatite B/sangue , Anticorpos Anti-Hepatite B/imunologia , Fatores Etários , Inflamação/sangue , Inflamação/imunologia , Idoso , Tireotropina/sangue , Anticorpos Anti-Hepatite A/sangue , Adolescente , Tiroxina/sangue
2.
PLoS One ; 19(7): e0306753, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38980873

RESUMO

BACKGROUND: Hepatitis A virus (HAV) is the predominant cause of acute viral hepatitis worldwide; however, data on HAV antibody prevalence (seroprevalence) among migrant populations are limited. This study aimed to investigate HAV seroprevalence among Qatar's migrant craft and manual workers (CMWs), constituting approximately 60% of the country's population. METHODS: HAV antibody testing was conducted on stored serum specimens obtained from CMWs during a nationwide severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) population-based cross-sectional survey between July 26 and September 9, 2020. Associations with HAV infection were investigated through regression analyses. RESULTS: Of the 2,607 specimens with HAV antibody test results, 2,393 were positive, and 214 were negative. The estimated HAV seroprevalence among CMWs was 92.0% (95% CI: 90.9-93.1%). HAV seroprevalence was generally high but exhibited some variation, ranging from 70.9% (95% CI: 62.4-78.2%) among Sri Lankans to 99.8% (95% CI: 98.2-99.9%) among Pakistanis. The multivariable regression analysis identified age, nationality, and educational attainment as statistically significant factors associated with HAV infection. Relative to CMWs aged ≤29 years, the adjusted relative risk (ARR) was 1.06 (95% CI: 1.03-1.10) in CMWs aged 30-39 years and reached 1.15 (95% CI: 1.10-1.19) in those aged ≥50 years. In comparison to Indians, the ARR was lower among Sri Lankans, assessed at 0.81 (95% CI: 0.72-0.91), but higher among Nepalese at 1.07 (95% CI: 1.04-1.11), Bangladeshis at 1.10 (95% CI: 1.07-1.13), Pakistanis at 1.12 (95% CI: 1.09-1.15), and Egyptians at 1.15 (95% CI: 1.08-1.23). No evidence for differences was found by geographic location or occupation. CONCLUSIONS: HAV seroprevalence among Qatar's CMW population is very high, with over nine out of every ten individuals having been exposed to this infection, likely during childhood.


Assuntos
Hepatite A , Migrantes , Humanos , Catar/epidemiologia , Hepatite A/epidemiologia , Hepatite A/sangue , Feminino , Masculino , Adulto , Estudos Soroepidemiológicos , Migrantes/estatística & dados numéricos , Pessoa de Meia-Idade , Estudos Transversais , Prevalência , Adulto Jovem , Vírus da Hepatite A/imunologia , Adolescente , Anticorpos Anti-Hepatite A/sangue , COVID-19/epidemiologia , COVID-19/virologia
3.
Spectrochim Acta A Mol Biomol Spectrosc ; 320: 124581, 2024 Nov 05.
Artigo em Inglês | MEDLINE | ID: mdl-38850829

RESUMO

Computer-aided vibrational spectroscopy detection technology has achieved promising results in the field of early disease diagnosis. Yet limited by factors such as the number of actual samples and the cost of spectral acquisition in clinical medicine, the data available for model training are insufficient, and the amount of data varies greatly between different diseases, which constrain the performance optimization and enhancement of the diagnostic model. In this study, vibrational spectroscopy data of three common diseases are selected as research objects, and experimental research is conducted around the class imbalance situation that exists in medical data. When dealing with the challenge of class imbalance in medical vibrational spectroscopy research, it no longer relies on some kind of independent and single method, but considers the combined effect of multiple strategies. SVM, K-Nearest Neighbor (KNN), and Decision Tree (DT) are used as baseline comparison models on Raman spectroscopy medical datasets with different imbalance rates. The performance of the three strategies, Ensemble Learning, Feature Extraction, and Resampling, is verified on the class imbalance dataset by G-mean and AUC metrics, respectively. The results show that all the above three methods mitigate the negative impact caused by unbalanced learning. Based on this, we propose a hybrid ensemble classifier (HEC) that integrates resampling, feature extraction, and ensemble learning to verify the effectiveness of the hybrid learning strategy in solving the class imbalance problem. The G-mean and AUC values of the HEC method are 82.7 % and 83.12 % for the HBV dataset, is 2.02 % and 1.98 % higher than the optimal strategy; 83.62 % and 83.76 % for the HCV dataset, is 9.79 % and 8.47 % higher than the optimal strategy; while for the thyroid dysfunction dataset are 77.56 % and 77.85 %, is 6.92 % and 6.36 % higher than that of the optimal strategy, respectively. The experimental results show that the G-mean and AUC metrics of the HEC method are higher than those of the baseline classifier as well as the optimal combination using separate strategies. It can be seen that the HEC method can effectively counteract the unfavorable effects of imbalance learning and is expected to be applied to a wider range of imbalance scenarios.


Assuntos
Hepatite A , Hepatite B , Análise Espectral Raman , Análise Espectral Raman/métodos , Humanos , Hepatite B/diagnóstico , Hepatite B/sangue , Hepatite A/diagnóstico , Hepatite A/sangue , Doenças da Glândula Tireoide/diagnóstico , Doenças da Glândula Tireoide/sangue , Máquina de Vetores de Suporte , Algoritmos , Aprendizado de Máquina , Árvores de Decisões
4.
Indian J Med Microbiol ; 49: 100572, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38552843

RESUMO

PURPOSE: The present study was conducted retrospectively to assess the frequency of acute viral hepatitis among the clinically suspected dengue cases presented at our tertiary care centre during 2021. METHODS: To determine the presence of acute viral hepatitis; Hepatitis A virus (HAV) and Hepatitis E virus (HEV) infections, 104 specimens were selected from the dengue-suspected clinical specimens received during 2021 on the basis of acute viral hepatitis symptoms. Following this, serological diagnosis was performed on those samples using anti-HAV IgM and anti-HEV IgM ELISA kits. RESULTS: Based on sero-positivity for IgM antibodies, 3 (5.3%) dengue virus (DENV) seropositive samples were positive for both HAV and HEV, while among DENV seronegative cases, 11 (22.91%) samples were positive for HEV and 1 (2.08%) sample was positive for HAV, pointing towards misdiagnosis due to overlapping symptoms. Additionally, co-infection of HAV & HEV in 1 sample was also observed in this study. CONCLUSIONS: This study revealed the presence of acute hepatitis infections among the dengue cases during monsoon and post-monsoon season. Overlapping of the clinical manifestations of these diseases can create misdiagnosis incidences raising risk for underreporting of the true cases of acute viral hepatitis infection. Dengue-suspected patients with selected symptoms during the monsoon and post-monsoon season should additionally be screened for acute hepatitis infections, as suggested in this study.


Assuntos
Dengue , Imunoglobulina M , Centros de Atenção Terciária , Humanos , Dengue/epidemiologia , Índia/epidemiologia , Estudos Retrospectivos , Centros de Atenção Terciária/estatística & dados numéricos , Estudos Soroepidemiológicos , Imunoglobulina M/sangue , Masculino , Feminino , Adulto , Hepatite E/epidemiologia , Hepatite A/epidemiologia , Hepatite A/sangue , Vírus da Dengue/imunologia , Pessoa de Meia-Idade , Adolescente , Adulto Jovem , Coinfecção/epidemiologia , Coinfecção/virologia , Ensaio de Imunoadsorção Enzimática , Vírus da Hepatite E/imunologia
5.
Vox Sang ; 119(6): 624-629, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38482941

RESUMO

BACKGROUND AND OBJECTIVES: In Canada, plasma sent for fractionation is tested for both parvovirus B19 (B19V) and hepatitis A virus (HAV). This study compared positivity rates of B19 and HAV nucleic acid tests (NATs) in Canadian plasma samples for the pre-COVID-19 restriction era (2015 to end of February 2020 [Q1] 2020) and the post-COVID-19 restriction era. MATERIALS AND METHODS: Pooled EDTA plasma specimens were tested within 24 months of blood draw using the Procleix Panther System (Grifols Diagnostic Solutions Inc, San Diego, CA, USA) for B19V and HAV detection. Reactive pools were resolved by individual specimen testing. RESULTS: Between 1 January 2015, and 31 March 2022, 3,928,619 specimens from Canadian plasma donors were tested for B19V. For the same period, 3,922,954 specimens were tested for HAV. To account for a lag in specimen testing for up to 24 months, the data were divided into: (1) a pre-pandemic period (1 January 2015-31 March 2020; B19V tested n = 2,412,701, B19V NAT-positive n = 240 [0.01%], HAV tested n = 2,407,036, HAV NAT-positive n = 26 [0.001%]); (2) a two-year mixed-impact period (1 April 2020-31 March 2022; B19V tested n = 968,250, B19V NAT-positive n = 14 [0.001%], HAV tested n = 968,250, HAV NAT-positive n = 2 [0.0002%]); and (3) a pandemic-impact period (1 April 2022-31 March, 2023; B19V tested n = 597,668, B19V NAT-positive n = 3 [0.0005%], HAV tested n = 597,668, HAV NAT-positive n = 1 [0.0002%]). CONCLUSION: The percentage of B19V- and HAV-positive donations was significantly reduced from the pre-pandemic period to the pandemic-impact period.


Assuntos
Doadores de Sangue , COVID-19 , Parvovirus B19 Humano , Humanos , COVID-19/sangue , COVID-19/epidemiologia , Canadá/epidemiologia , Hepatite A/sangue , Hepatite A/epidemiologia , SARS-CoV-2 , Masculino , Feminino , Vírus da Hepatite A , Infecções por Parvoviridae/sangue , Infecções por Parvoviridae/epidemiologia
6.
Indian J Med Microbiol ; 43: 96-100, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36481121

RESUMO

With the changing hepatitis A epidemiology in India, focal viral outbreaks are being reported from different parts of the country. This study presents Hepatitis A Virus (HAV) strain characterization (period 2009-2020) from 18 states of India. For that, blood and stool samples (n â€‹= â€‹280) were screened for HAV RNA and sequences for 5'non-coding and VP3 regions were generated from positive samples (n â€‹= â€‹68). Presence of a single IIIA genotype in all samples indicated IIIA being the only HAV genotype currently circulating in India. Interestingly, it was evident that these strains form two distinct groups suggesting independent evolution of these two clusters.


Assuntos
Vírus da Hepatite A Humana , Hepatite A , Vírus da Hepatite A Humana/classificação , Vírus da Hepatite A Humana/genética , Vírus da Hepatite A Humana/isolamento & purificação , Índia/epidemiologia , Genótipo , Filogenia , Fezes/química , Fezes/virologia , Hepatite A/sangue , Hepatite A/epidemiologia , Hepatite A/virologia , Humanos , RNA Viral/análise
7.
Viruses ; 14(2)2022 02 01.
Artigo em Inglês | MEDLINE | ID: mdl-35215897

RESUMO

This study aims to evaluate the epidemiological and molecular features associated with HAV transmission in adults in Rio de Janeiro during a period of increased registered cases of HAV (2017-2018). Socio-epidemiological data and serum samples from anti-HAV IgM+ individuals were obtained. HAV RNA was RT-PCR amplified and sequenced for further phylogenetic and phylogeographic analyses. From fifty-two HAV IgM+ individuals, most were men (78.85%; p = 0.024), aged 20-30 years old (84.61%; p < 0.001), resided in the Rio de Janeiro north zone (31/52; 59.62%; p = 0.001), and are men who have sex with men (MSM) (57.69%; p = 0.002). Sexual practices were more frequent (96%) than others risk factors (food-borne (44%), water-borne (42.31%), and parenteral (34.62%)). Individuals who traveled to endemic regions had a 7.19-fold (1.93-36.04; p < 0.01) increased risk of HAV. Phylogenetic analysis revealed four distinct clades of subgenotype IA, three of them comprised sequences from European/Asian MSM outbreaks and one from Brazilian endemic strains. Bayesian Inference showed that the imported strains were introduced to Brazil during large mass sportive events. Sexual orientation and sexual practices may play a role in acquiring HAV infection. Public policies targeting key populations must be implemented to prevent further dissemination of HAV and other STIs.


Assuntos
Vírus da Hepatite A/isolamento & purificação , Hepatite A/epidemiologia , Hepatite A/virologia , Adulto , Anticorpos Antivirais/sangue , Brasil , Estudos Transversais , Genótipo , Hepatite A/sangue , Hepatite A/transmissão , Vírus da Hepatite A/classificação , Vírus da Hepatite A/genética , Vírus da Hepatite A/imunologia , Homossexualidade Masculina/psicologia , Homossexualidade Masculina/estatística & dados numéricos , Humanos , Imunoglobulina M/sangue , Masculino , Filogenia , Filogeografia , Comportamento Sexual , Adulto Jovem
8.
Am Fam Physician ; 104(4): 368-374, 2021 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-34652109

RESUMO

Hepatitis A is a common viral infection worldwide that is transmitted via the fecal-oral route. The incidence of infection in the United States decreased by more than 90% after an effective vaccine was introduced, but the number of cases has been increasing because of large community outbreaks in unimmunized individuals. Classic symptoms include fever, malaise, dark urine, and jaundice and are more common in older children and adults. People are most infectious 14 days before and seven days after the development of jaundice. Diagnosis of acute infection requires the use of serologic testing for immunoglobulin M anti-hepatitis A antibodies. The disease is usually self-limited, supportive care is often sufficient for treatment, and chronic infection or chronic liver disease does not occur. Routine hepatitis A immunization is recommended in children 12 to 23 months of age. Immunization is also recommended for individuals at high risk of contracting the infection, such as persons who use illegal drugs, those who travel to areas endemic for hepatitis A, incarcerated populations, and persons at high risk of complications from hepatitis A, such as those with chronic liver disease or HIV infection. The vaccine is usually recommended for pre- and postexposure prophylaxis, but immune globulin can be used in patients who are too young to be vaccinated or if the vaccine is contraindicated.


Assuntos
Vacinas contra Hepatite A/imunologia , Hepatite A/prevenção & controle , Adolescente , Adulto , Alanina Transaminase/sangue , Criança , Pré-Escolar , Hepatite A/sangue , Hepatite A/diagnóstico , Hepatite A/transmissão , Vacinas contra Hepatite A/administração & dosagem , Humanos , Lactente , Pessoa de Meia-Idade , Profilaxia Pós-Exposição/métodos , Fatores de Risco , Adulto Jovem
9.
PLoS One ; 16(4): e0250505, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33914782

RESUMO

In the summer of 2017, an estimated 745,000 Rohingya fled to Bangladesh in what has been described as one of the largest and fastest growing refugee crises in the world. Among numerous health concerns, an outbreak of acute jaundice syndrome (AJS) was detected by the disease surveillance system in early 2018 among the refugee population. This paper describes the investigation into the increase in AJS cases, the process and results of the investigation, which were strongly suggestive of a large outbreak due to hepatitis A virus (HAV). An enhanced serological investigation was conducted between 28 February to 26 March 2018 to determine the etiologies and risk factors associated with the outbreak. A total of 275 samples were collected from 18 health facilities reporting AJS cases. Blood samples were collected from all patients fulfilling the study specific case definition and inclusion criteria, and tested for antibody responses using enzyme-linked immunosorbent assay (ELISA). Out of the 275 samples, 206 were positive for one of the agents tested. The laboratory results confirmed multiple etiologies including 154 (56%) samples tested positive for hepatitis A, 1 (0.4%) positive for hepatitis E, 36 (13%) positive for hepatitis B, 25 (9%) positive for hepatitis C, and 14 (5%) positive for leptospirosis. Among all specimens tested 24 (9%) showed evidence of co-infections with multiple etiologies. Hepatitis A and E are commonly found in refugee camps and have similar clinical presentations. In the absence of robust testing capacity when the epidemic was identified through syndromic reporting, a particular concern was that of a hepatitis E outbreak, for which immunity tends to be limited, and which may be particularly severe among pregnant women. This report highlights the challenges of identifying causative agents in such settings and the resources required to do so. Results from the month-long enhanced investigation did not point out widespread hepatitis E virus (HEV) transmission, but instead strongly suggested a large-scale hepatitis A outbreak of milder consequences, and highlighted a number of other concomitant causes of AJS (acute hepatitis B, hepatitis C, Leptospirosis), albeit most likely at sporadic level. Results strengthen the need for further water and sanitation interventions and are a stark reminder of the risk of other epidemics transmitted through similar routes in such settings, particularly dysentery and cholera. It also highlights the need to ensure clinical management capacity for potentially chronic conditions in this vulnerable population.


Assuntos
Surtos de Doenças , Vírus da Hepatite A/isolamento & purificação , Hepatite A/epidemiologia , Icterícia/epidemiologia , Adolescente , Bangladesh/epidemiologia , Criança , Pré-Escolar , Feminino , Hepacivirus/genética , Hepacivirus/patogenicidade , Hepatite A/sangue , Hepatite A/virologia , Vírus da Hepatite A/patogenicidade , Hepatite B/sangue , Hepatite B/epidemiologia , Hepatite B/virologia , Vírus da Hepatite B/genética , Vírus da Hepatite B/patogenicidade , Hepatite C/sangue , Hepatite C/epidemiologia , Hepatite C/virologia , Hepatite E/sangue , Hepatite E/epidemiologia , Hepatite E/virologia , Vírus da Hepatite E/genética , Vírus da Hepatite E/patogenicidade , Humanos , Lactente , Recém-Nascido , Icterícia/sangue , Icterícia/patologia , Icterícia/virologia , Leptospirose/sangue , Leptospirose/epidemiologia , Leptospirose/parasitologia , Leptospirose/patologia , Masculino , Gravidez , Campos de Refugiados , Refugiados , Fatores de Risco , Populações Vulneráveis
10.
Sci Rep ; 11(1): 4778, 2021 02 26.
Artigo em Inglês | MEDLINE | ID: mdl-33637853

RESUMO

This study determined the prevalence of total hepatitis A antibody (anti-HAV) among 5-7 years old children and their mothers in the whole Cambodia, using a nationwide study, and examined the differences between the two cohorts. A total of 4535 dried blood spot-driven (DBS) samples (2021 mothers and their 2514 children of 5-7 years old) and the concomitant 922 whole blood samples (subset of the whole participants) were collected using a multistage random sampling strategy throughout Cambodia in 2017. Total anti-HAV was detected using the chemiluminescence enzyme immunoassay method. Compared to gold standard whole blood samples, the sensitivity and specificity of DBS mediated anti-HAV detection were 94.8% and 98%, respectively. Total anti-HAV prevalence among mothers was 91.2% (95%CI: 90.0-92.5%), and that of their children was 31.5% (95%CI: 29.7-33.3%). In our study, the low prevalence of total anti-HAV among children indicates the country's improvement of safe water and food supply, hygiene and sanitation. If the hygiene and sanitation are consistently improved in Cambodia, the prevalence might be no longer increased when the children become adults.


Assuntos
Anticorpos Anti-Hepatite A/sangue , Vírus da Hepatite A Humana/isolamento & purificação , Hepatite A/sangue , Camboja/epidemiologia , Criança , Pré-Escolar , Feminino , Hepatite A/epidemiologia , Hepatite A/imunologia , Anticorpos Anti-Hepatite A/imunologia , Vírus da Hepatite A Humana/imunologia , Humanos , Masculino , Prevalência , Estudos Soroepidemiológicos
11.
J Med Virol ; 93(6): 3991-3994, 2021 06.
Artigo em Inglês | MEDLINE | ID: mdl-33448443

RESUMO

The hepatitis A vaccine is recommended for all children greater than or equal to 1 year of age, however, the duration of vaccine protection is unknown and protection through adulthood is crucial to prevent symptomatic hepatitis later in life. We report on 25 years of follow-up of a cohort of Alaska Native individuals who were vaccinated in early childhood. We assessed the duration of vaccine protection by calculating the geometric mean concentration and proportion of participants with protective levels of IgG antibody to hepatitis A virus (anti-HAV) (≥20 mIU/mL) every 2 to 3 years. We estimated the amount of time until the anti-HAV dropped below protective levels using survival analyses. At 25 years, 43 of the original 144 participants were available, mean anti-HAV levels were 91.5 mIU/mL, and 35 (81.4%) had protective levels of anti-HAV. Using data from all persons and all time points, a survival analysis estimated 78.7% of participants had protective levels of anti-HAV at 25 years. The high level of protective antibodies in this cohort indicate that supplemental doses of hepatitis A vaccine are not needed 25 years after completion of the vaccine series.


Assuntos
Anticorpos Anti-Hepatite A/sangue , Vacinas contra Hepatite A/imunologia , Hepatite A/imunologia , Hepatite A/prevenção & controle , Imunogenicidade da Vacina , Alaska/epidemiologia , Pré-Escolar , Estudos de Coortes , Feminino , Seguimentos , Hepatite A/sangue , Hepatite A/epidemiologia , Vacinas contra Hepatite A/administração & dosagem , Humanos , Imunização Secundária , Imunoglobulina G/sangue , Masculino , Fatores de Tempo , Vacinação/estatística & dados numéricos
12.
J Med Virol ; 93(6): 3666-3671, 2021 06.
Artigo em Inglês | MEDLINE | ID: mdl-32986240

RESUMO

Hepatitis A infections still represent a major global health concern. During the past years, a transition pattern of the hepatitis A epidemiology was noted in many parts of the world. In Tunisia, there is not a recent survey on age-specific hepatitis A virus seroprevalence. This study aimed to investigate the seroprevalence of hepatitis A virus infection in Central-West Tunisia, representative of regions with lowest socioeconomic level in the country, before vaccine implementation. Sera obtained from the blood samples of subjects were screened for the detection of hepatitis A virus. The seroprevalence was evaluated by detection of total antibodies to hepatitis A virus using commercially available immunoassay kits. A total of 1379 subjects, aged 5-75 years (mean age: 29.0 ± 17.3 years) were studied. The global anti-hepatitis A virus seroplevalence was 84.7% (95% confidence interval: [82.6-86.5]). A higher hepatitis A virus seroprevalence was showed in subjects aged 10-14 years compared to those aged less than 10 years (50.0% vs. 31.0%). In subjects aged 20-29 years, a rapid increase in the hepatitis A virus prevalence was noted; it reached 97.0%. The seroprevalence of anti-hepatitis A virus differed by zone of residence (81.1% in rural area vs. 72.4% in urban area, p = .005) and increased significantly with lower level of education (p = .019). There was no statistical significant seroprevalence difference between male and female: 84.2% versus 85.2%, respectively. Our study confirm the transition pattern of the hepatitis A virus endemicity in Tunisia from high to intermediate and provide an evaluation of the hepatitis A virus epidemiological situation before vaccine implementation.


Assuntos
Vírus da Hepatite A/imunologia , Hepatite A/epidemiologia , Hepatite A/imunologia , Adolescente , Adulto , Idoso , Criança , Pré-Escolar , Feminino , Hepatite A/sangue , Anticorpos Anti-Hepatite A/sangue , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , Fatores de Risco , Estudos Soroepidemiológicos , Tunísia/epidemiologia , Adulto Jovem
13.
J Infect Dev Ctries ; 14(12): 1475-1479, 2020 12 31.
Artigo em Inglês | MEDLINE | ID: mdl-33378294

RESUMO

INTRODUCTION: Hepatitis A virus causes an acute infection mainly in young children. The present study was carried out to characterize the nature of hepatitis A virus (HAV) involved in an outbreak of jaundice in children. METHODOLOGY: Serum and stool samples from five children were sampled from among 26 clinically diagnosed jaundice cases. HAV IgM ELISA and PCR were used for confirmatory diagnosis and molecular characterization by direct amplicon sequencing and analysis. RESULTS: All the serum samples collected from the symptomatic cases were found to be positive for Anti-HAV IgM ELISA as were all the serum samples and stool samples using semi-nested PCR. Phylogenetic analysis revealed that the HAV involved in the outbreak belonged to genotype IIIA. CONCLUSIONS: The infection was caused by HAV genotype IIIA. Improved access to clean drinking water, sanitation around drinking water sources and routine chlorination of drinking water in poor and developing countries are needed, as well as childhood HAV vaccination under regular immunization programs in endemic countries.


Assuntos
Surtos de Doenças , Genótipo , Vírus da Hepatite A/genética , Hepatite A/epidemiologia , Icterícia/virologia , Adolescente , Anticorpos Antivirais/sangue , Criança , Pré-Escolar , Fezes/virologia , Feminino , Hepatite A/sangue , Hepatite A/complicações , Vírus da Hepatite A/classificação , Humanos , Índia/epidemiologia , Lactente , Recém-Nascido , Icterícia/sangue , Icterícia/epidemiologia , Masculino , Filogenia , RNA Viral/sangue , RNA Viral/genética , Adulto Jovem
14.
PLoS One ; 15(12): e0240339, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33306686

RESUMO

BACKGROUND: Hepatitis A virus (HAV) infection is one of the major causes of acute viral hepatitis. HAV genotypes and its genetic diversity is rarely investigated in our region as well as worldwide. AIMS: The aims of the present study were to determine the HAV genotypes and its risk factors and to investigate the genetic diversity of the HAV isolates in the West Bank, Palestine. STUDY DESIGN: A cohort of 161 clinically and laboratory-confirmed HAV (IgM-positive) cases and 170 apparently healthy controls from all the districts of the West Bank, Palestine during the period of 2014 to 2016 were tested for HAV infection using IgM antibodies, RT-PCR and sequence analysis of the VP3/VP1 junction region of the HAV genome. Phylogenetic analysis, genetic diversity and haplotypes analysis were used to characterize the VP3/VP1 sequences. RESULTS: All the 34 sequences of the HAV were found to be of HAV-IB sub-genotype. The phylogenetic analysis showed four main clusters with cluster III exclusively consisting of 18 Palestinian isolates (18/23-78%), but with weak bootstrap values. A high haplotype diversity (Hd) and low nucleotide diversity (π) were observed. Cluster III showed high number of haplotypes (h = 8), but low haplotype (gene) diversity (Hd = 0.69). A total of 28 active haplotypes with some consisting of more than one sequence were observed using haplotype network analysis. The Palestinian haplotypes are characterized by closely related viral haplotypes with one SNV away from each other which ran parallel to cluster III in the phylogenetic tree. A smaller Palestinian haplotype (4 isolates) was three SNVs away from the major haplotype cluster (n = 10) and closer to others haplotypes from Iran, Spain, and South Africa. Young age, low level of parent's education, infrequent hand washing before meals, and drinking of un-treated water were considered the major HAV risk factors in the present study. CONCLUSION: Haplotype network analysis revealed haplotype variation among the HAV Palestinian sequences despite low genetic variation and nucleotide diversity. In addition, this study reconfirmed that age and parent's level of education as HAV risk factors, while hand washing and treating drinking water as protective factors.


Assuntos
Vírus da Hepatite A Humana/genética , Hepatite A/epidemiologia , Hepatite A/virologia , Adolescente , Adulto , Fatores Etários , Substituição de Aminoácidos , Anticorpos Antivirais/sangue , Anticorpos Antivirais/isolamento & purificação , Estudos de Casos e Controles , Criança , Pré-Escolar , Estudos Transversais , Escolaridade , Feminino , Genoma Viral/genética , Haplótipos , Hepatite A/sangue , Hepatite A/diagnóstico , Vírus da Hepatite A Humana/isolamento & purificação , Humanos , Imunoglobulina M/sangue , Imunoglobulina M/imunologia , Masculino , Oriente Médio/epidemiologia , Epidemiologia Molecular , Filogenia , Polimorfismo de Nucleotídeo Único , RNA Viral/genética , RNA Viral/isolamento & purificação , Fatores de Risco , Análise de Sequência de DNA , Adulto Jovem
15.
BMC Infect Dis ; 20(1): 627, 2020 Aug 26.
Artigo em Inglês | MEDLINE | ID: mdl-32842988

RESUMO

BACKGROUND: The epidemiological pattern of hepatitis A infection has shown dynamic changes in many parts of the world due to improved socio-economic conditions and the accumulation of seronegative subjects, which leads to possible outbreaks and increased morbidity rate. In Tunisia, the epidemiological status of hepatits A virus is currently unknown. However, over the past years higher numbers of symptomatic hepatitis A virus infection in school attendants and several outbreaks were reported to the Ministry of Health, especially from regions with the lowest socio-economic levels in the country. The aim of this study was to investigate the current seroprevalence of hepatitis A virus antibodies in central-west Tunisia and assess the impact of hepatitis A virus vaccination on hepatitis A epidemiology. METHODS: Serum samples from 1379 individuals, aged 5-75 years, were screened for hepatitis A virus antibodies. Adjusted seroprevalence, incidence and force of infection parameters were estimated by a linear age structured SEIR (Susceptible-Exposed-Infectious-Recovered) compartmental model. A vaccine model was then constructed to assess the impact on hepatitis A virus epidemiology of 3 scenarios of vaccination strategies: one dose at 12-months of age, one dose at 6-years and one dose at 12-months and another at 6-years of age during 6 years. RESULTS: A rapid increase in anti-hepatitis A virus seroprevalence was noted during infancy and adolescence: 47% of subjects under 10-years-old are infected; the prevalence increases to 77% at 15-years and reaches 97% in subjects aged 30-years. The force of infection is highest between 10 and 30-years of age and the incidence declines with increasing age. The vaccine model showed that the 3-scenarios lead to a significant reduction of the fraction of susceptibles. The two doses scenario gives the best results. Single-dose vaccination at 6-years of age provides more rapid decrease of disease burden in school-aged children, as compared to single-dose vaccination at 12-months, but keeps with a non-negligible fraction of susceptibles among children < 6-years. CONCLUSIONS: Our study confirms the epidemiological switch from high to intermediate endemicity of hepatitis A virus in Tunisia and provides models that may help undertake best decisions in terms of vaccinations strategies.


Assuntos
Vírus da Hepatite A/imunologia , Hepatite A/epidemiologia , Hepatite A/transmissão , Modelos Teóricos , Vacinação/métodos , Adolescente , Adulto , Fatores Etários , Idoso , Criança , Pré-Escolar , Feminino , Hepatite A/sangue , Hepatite A/prevenção & controle , Anticorpos Anti-Hepatite A/sangue , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Prevalência , Estudos Soroepidemiológicos , Tunísia/epidemiologia , Adulto Jovem
16.
BMC Infect Dis ; 20(1): 529, 2020 Jul 22.
Artigo em Inglês | MEDLINE | ID: mdl-32698841

RESUMO

BACKGROUND: The risk of viral hepatitis among healthcare students (HCSs) is greater than that among the general population. Therefore, this study was conducted to investigate the seroprevalence of the hepatitis A virus (HAV), hepatitis B virus (HBV) and hepatitis C virus (HCV) among first-year HCSs at a university in Turkey and as a secondary objective, to determine the factors associated with HAV and HBV seropositivity. METHODS: This cross-sectional study was performed in first-year HCSs in Izmir, western Turkey. Data were collected using a self-administered questionnaire including items on sociodemographic characteristics, medical history, and hygiene. A total of 650 HCSs were tested for the HAV, HBV and HCV markers. Categorical variables were compared using the chi-square test. The association between independent variables and anti-HAV seropositivity and anti-HBs seropositivity was assessed by multinomial logistic regression analysis. RESULTS: The overall frequency of total anti-HAV seropositivity was 34.9%. HBsAg, total anti-HBc and anti-HBs seropositivity were found in 0.3, 1.2 and 93.7% of samples, respectively. All of the HCSs were negative for anti-HCV. Total anti-HAV seropositivity was found to be 1.73 times higher in those ≥21 years old, and it was 1.61 times higher in those who perceived their economic status to be average and 2.75 times higher in those who perceived their economic status to be low. Total anti-HAV seropositivity was found to be 4.37 times higher in those who lived in provinces with intermediate human development index levels. Total anti-HBs seropositivity was found to be 2.48 times higher in those ≤20 years old, and it was 2.13 times higher in those who perceived their economic status to be average. CONCLUSIONS: Approximately two out of three HCSs were susceptible to HAV infection. Since HCSs are at high risk for HAV infection, they should be vaccinated before medical clerkships begin. Our results indicate that there is a high prevalence of anti-HBs seropositivity among HCSs. This result may be largely attributed to the implementation of a successful vaccination program in Turkey since 1998.


Assuntos
Hepacivirus/imunologia , Vírus da Hepatite A/imunologia , Hepatite A/epidemiologia , Vírus da Hepatite B/imunologia , Hepatite B/epidemiologia , Hepatite C/epidemiologia , Estudantes de Medicina , Adolescente , Adulto , Estudos Transversais , Feminino , Hepatite A/sangue , Hepatite A/virologia , Hepatite B/sangue , Hepatite B/virologia , Anticorpos Anti-Hepatite B/sangue , Antígenos de Superfície da Hepatite B/sangue , Hepatite C/sangue , Hepatite C/virologia , Humanos , Programas de Imunização , Masculino , Prevalência , Autorrelato , Estudos Soroepidemiológicos , Turquia/epidemiologia , Adulto Jovem
17.
BMJ Open ; 10(6): e036727, 2020 06 07.
Artigo em Inglês | MEDLINE | ID: mdl-32513893

RESUMO

OBJECTIVES: Hepatitis A incidence in Korea has dramatically increased in recent years. Individuals in their twenties and thirties, who account for majority of the workforce in Korea, are particularly susceptible to infection owing to a low seroprevalence of anti-hepatitis A virus (anti-HAV) immunoglobulin G (IgG). This study aimed to identify behavioural and occupational factors related to anti-HAV IgG seropositivity. DESIGN: Cross-sectional study. SETTING: A large university hospital in Seoul, Korea. PARTICIPANTS: Workers in formal employment having an annual routine health screening. PRIMARY OUTCOME MEASURE: Anti-HAV IgG seropositivity. RESULTS: Of 131 711 individuals who had an annual health screening at the study hospital in 2018, 68 612 met the inclusion criteria and were included in the analysis. Study participants were predominantly men (64.3%) and in their thirties (55.3%). The overall seroprevalence of anti-HAV IgG was 36.2%. In multivariate analyses, anti-HAV IgG seropositivity was independently associated with working in a workplace with ≥2 health managers (vs no health manager, adjusted OR 1.32, 95% CI 1.22 to 1.43); age 40-49 years (vs 20-29 years, OR 2.51, 95% CI 2.36 to 2.68); female sex (OR 1.54, 95% CI 1.48 to 1.59); experience of any general disease (vs no general disease history, OR 1.19, 95% CI 1.14 to 1.25), obesity (vs normal weight, OR 0.91, 95% CI 0.86 to 0.97); and hepatitis B antibody seropositivity (OR 2.39, 95% CI 2.31 to 2.49). CONCLUSIONS: The low prevalence of anti-HAV IgG seropositivity points to a need for implementation of workplace-based hepatitis A vaccine programmes. To promote workers' health and prevent hepatitis A outbreaks, occupational health managers, healthcare providers and policy-makers should focus on individuals who are susceptible to HAV, such as young men.


Assuntos
Pessoal de Saúde , Hepatite A/epidemiologia , Doenças Profissionais/epidemiologia , Adulto , Estudos Transversais , Feminino , Hepatite A/sangue , Hepatite A/prevenção & controle , Anticorpos Anti-Hepatite A/sangue , Vírus da Hepatite A Humana/imunologia , Hospitais Universitários , Humanos , Imunoglobulina G/sangue , Masculino , Pessoa de Meia-Idade , Doenças Profissionais/sangue , Doenças Profissionais/prevenção & controle , República da Coreia/epidemiologia , Estudos Soroepidemiológicos , Adulto Jovem
18.
J Hepatol ; 73(3): 640-650, 2020 09.
Artigo em Inglês | MEDLINE | ID: mdl-32247824

RESUMO

BACKGROUND & AIMS: Mucosal-associated invariant T (MAIT) cells, the most abundant innate-like T cells in the human liver, can be activated by cytokines during viral infection without TCR stimulation. Here, we examined the mechanisms underlying TCR/MR1-independent innate-like cytotoxicity of cytokine-activated liver MAIT cells. We also examined the phenotype and function of MAIT cells from patients with acute viral hepatitis. METHODS: We obtained liver sinusoidal mononuclear cells from donor liver perfusate during liver transplantation and examined the effect of various cytokines on liver MAIT cells using flow cytometry and in vitro cytotoxicity assays. We also obtained peripheral blood and liver-infiltrating T cells from patients with acute hepatitis A (AHA) and examined the phenotype and function of MAIT cells using flow cytometry. RESULTS: IL-15-stimulated MAIT cells exerted granzyme B-dependent innate-like cytotoxicity in the absence of TCR/MR1 interaction. PI3K-mTOR signaling, NKG2D ligation, and CD2-mediated conjugate formation were critically required for this IL-15-induced innate-like cytotoxicity. MAIT cells from patients with AHA exhibited activated and cytotoxic phenotypes with higher NKG2D expression. The innate-like cytotoxicity of MAIT cells was significantly increased in patients with AHA and correlated with serum alanine aminotransferase levels. CONCLUSIONS: Taken together, the results demonstrate that liver MAIT cells activated by IL-15 exert NKG2D-dependent innate-like cytotoxicity in the absence of TCR/MR1 engagement. Furthermore, the innate-like cytotoxicity of MAIT cells is associated with liver injury in patients with AHA, suggesting that MAIT cells contribute to immune-mediated liver injury. LAY SUMMARY: Immune-mediated liver injury commonly occurs during viral infections of the liver. Mucosal-associated invariant T (MAIT) cells are the most abundant innate-like T cells in the human liver. Herein, we have identified a mechanism by which MAIT cells circumvent conventional T cell receptor interactions to exert cytotoxicity. We show that this innate-like cytotoxicity is increased during acute hepatitis A virus infection and correlates with the degree of hepatocyte injury.


Assuntos
Linfócitos T CD8-Positivos/imunologia , Citotoxicidade Imunológica/efeitos dos fármacos , Vírus da Hepatite A Humana , Hepatite A/sangue , Antígenos de Histocompatibilidade Classe I/metabolismo , Imunidade Inata/efeitos dos fármacos , Interleucina-15/farmacologia , Fígado/imunologia , Doadores Vivos , Antígenos de Histocompatibilidade Menor/metabolismo , Células T Invariantes Associadas à Mucosa/imunologia , Receptores de Antígenos de Linfócitos T/metabolismo , Doença Aguda , Adulto , Células Cultivadas , Feminino , Hepatite A/virologia , Humanos , Células Matadoras Naturais/imunologia , Transplante de Fígado/métodos , Ativação Linfocitária/efeitos dos fármacos , Masculino , Pessoa de Meia-Idade , Fenótipo , Adulto Jovem
19.
Am J Trop Med Hyg ; 103(1): 164-168, 2020 07.
Artigo em Inglês | MEDLINE | ID: mdl-32342836

RESUMO

Despite several recent reports of outbreaks of hepatitis A, little is known about the disease burden in Lao People's Democratic Republic (PDR). We conducted a cross-sectional age-stratified seroprevalence study of anti-hepatitis A virus (HAV) IgG and risk factors in a rural province (Xiengkhouang) and Vientiane capital in Lao PDR. Overall, 62% of participants were anti-HAV positive in Xiengkhouang Province compared with 45.5% in Vientiane capital. In Xiengkhouang, 23.7% of 5- to 10-year-olds were already seropositive compared with 5% in Vientiane. A dramatic increase in seroprevalence occurred between 15- to 20-year and 21- to 30-year age-groups (35.7-62.4%, Xiengkhouang, and 11.5-69.7%, Vientiane) until essentially all older adults were positive in both locations. The main risk factors for HAV antibodies were age, non-Lao-Tai ethnicity, and food-related risk factors. In conclusion, Lao children seem to be exposed very early to HAV, particularly in rural settings, and exposure continues throughout their lives, mostly without being reported. In the older birth cohorts, the high seroprevalence may largely reflect poor sanitation and exposure during childhood. In Vientiane capital, the lower seroprevalence at young ages may reflect better water sanitation since the late 1990s. A comparison with neighboring Thailand indicates that the impact of improved sanitation in Lao PDR began only two decades later. Further improvements in water sanitation, in particular in the rural districts, and better food hygiene are warranted. Our study also suggests that HAV infections are underreported. Improved reporting would provide guidance for targeted interventions to further reduce HAV infections.


Assuntos
Anticorpos Antivirais/sangue , Surtos de Doenças , Vírus da Hepatite A/imunologia , Hepatite A/epidemiologia , Imunoglobulina G/sangue , Adolescente , Adulto , Criança , Pré-Escolar , Estudos Transversais , Notificação de Doenças/estatística & dados numéricos , Feminino , Hepatite A/sangue , Hepatite A/imunologia , Hepatite A/virologia , Humanos , Laos/epidemiologia , Masculino , Pessoa de Meia-Idade , Fatores de Risco , População Rural , Saneamento/métodos , Estudos Soroepidemiológicos , Abastecimento de Água
20.
Adv Virus Res ; 108: 315-336, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33837720

RESUMO

Hepatitis A virus (HAV) and hepatitis E virus (HEV) infections are the main causes for acute hepatitis worldwide. Both viruses had long been considered as nonenveloped viruses. However, recent work has uncovered that both viruses circulate in the bloodstream as membrane-cloaked, "quasi-enveloped" particles that are, surprisingly, infectious and likely the only form mediating virus spread within the host. The discovery of quasi-enveloped HAV and HEV particles has fundamentally changed the traditional view on the life cycle and pathogenesis of these viruses. However, because HAV and HEV are phylogenetically unrelated and their capsid assembly processes are quite distinct, it is not clear whether they use similar or different mechanisms for envelopment and exit. This review provides an overview of the current knowledge about the assembly and exit processes of HAV and HEV and perspectives for future studies.


Assuntos
Vírus da Hepatite A/fisiologia , Vírus da Hepatite E/fisiologia , Envelope Viral , Montagem de Vírus , Liberação de Vírus , Livros , Capsídeo , Proteínas do Capsídeo/metabolismo , Membrana Celular/metabolismo , Hepatite A/sangue , Hepatite A/virologia , Vírus da Hepatite A/genética , Vírus da Hepatite A/patogenicidade , Hepatite E/sangue , Hepatite E/virologia , Vírus da Hepatite E/genética , Vírus da Hepatite E/patogenicidade , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...